• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在西方高容量中心,切除的胆道癌解剖亚型的短期和长期结果比较。

Comparison of short- and long-term outcomes between anatomical subtypes of resected biliary tract cancer in a Western high-volume center.

机构信息

Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, the Netherlands.

Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, the Netherlands.

出版信息

HPB (Oxford). 2020 Mar;22(3):405-414. doi: 10.1016/j.hpb.2019.07.011. Epub 2019 Sep 4.

DOI:10.1016/j.hpb.2019.07.011
PMID:31494056
Abstract

BACKGROUND

Outcomes for the four anatomical subtypes of biliary tract carcinoma (BTC) - intrahepatic, perihilar and distal cholangiocarcinoma (ICC, PHCC, DCC) and gallbladder carcinoma (GBC) - are often combined. However, large cohorts comparing short- and long-term outcomes for the anatomical subtypes of BTC are lacking.

METHODS

All patients who underwent resection for pathology proven ICC, PHCC, DCC or GBC (2000-2016) from a single Western high-volume center were retrospectively selected. Clinicopathological characteristics, short- and long-term outcomes were compared between the four anatomical subtypes.

RESULTS

Overall, 361 patients with resected BTC were included (33 ICC, 135 PHCC, 148 DCC, 45 GBC). Clavien-Dindo grade III or higher complications were 48%, 51%, 36% and 8% (p < 0.001) and 90-day mortality was 9%, 15%, 3%, 4% (p < 0.001), for ICC, PHCC, DCC, GBC. Median overall survival was 37, 42, 29 and 41 months (p = 0.722), for ICC, PHCC, DCC, GBC. Five-year survival ranged between 29% and 37%. Anatomical subtype was not an independent predictor for overall survival.

CONCLUSION

In this large single-center cohort of resected BTC, major morbidity and 90-day mortality varied between the four anatomical subtypes of BTC, mainly due to differences in surgical approach However, a significant difference in overall survival was not detected.

摘要

背景

四种解剖学亚型的胆道癌(BTC)——肝内、肝门周围和远端胆管癌(ICC、PHCC、DCC)和胆囊癌(GBC)——的预后通常被合并在一起。然而,缺乏比较 BTC 解剖学亚型的短期和长期结果的大型队列研究。

方法

回顾性地选择了来自单一西方大容量中心的经病理证实的 ICC、PHCC、DCC 或 GBC 患者(2000-2016 年),并对其进行手术切除。比较了四种解剖学亚型的临床病理特征、短期和长期结果。

结果

共纳入 361 例接受 BTC 切除术的患者(33 例 ICC、135 例 PHCC、148 例 DCC、45 例 GBC)。Clavien-Dindo 分级 III 或更高的并发症发生率分别为 48%、51%、36%和 8%(p<0.001),90 天死亡率分别为 9%、15%、3%、4%(p<0.001),ICC、PHCC、DCC、GBC。ICC、PHCC、DCC 和 GBC 的中位总生存期分别为 37、42、29 和 41 个月(p=0.722)。5 年生存率在 29%至 37%之间。解剖学亚型不是总生存期的独立预测因素。

结论

在这项大型单中心 BTC 切除患者队列研究中,四种 BTC 解剖学亚型之间的主要发病率和 90 天死亡率存在差异,主要是由于手术方法的不同。然而,总体生存无显著差异。

相似文献

1
Comparison of short- and long-term outcomes between anatomical subtypes of resected biliary tract cancer in a Western high-volume center.在西方高容量中心,切除的胆道癌解剖亚型的短期和长期结果比较。
HPB (Oxford). 2020 Mar;22(3):405-414. doi: 10.1016/j.hpb.2019.07.011. Epub 2019 Sep 4.
2
Prognostic value of preoperative inflammatory markers in resectable biliary tract cancer - Validation and comparison of the Glasgow Prognostic Score and Modified Glasgow Prognostic Score in a Western cohort.术前炎症标志物对可切除胆道癌的预后价值 - 西方队列中格拉斯哥预后评分和改良格拉斯哥预后评分的验证和比较。
Eur J Surg Oncol. 2020 May;46(5):804-810. doi: 10.1016/j.ejso.2019.12.008. Epub 2019 Dec 14.
3
Landscape of distant metastasis mode and current chemotherapy efficacy of the advanced biliary tract cancer in the United States, 2010-2016.2010-2016 年美国晚期胆道癌远处转移模式及当前化疗疗效的研究。
Cancer Med. 2020 Feb;9(4):1335-1348. doi: 10.1002/cam4.2794. Epub 2019 Dec 26.
4
Serum CYFRA 21-1 in Biliary Tract Cancers: A Reliable Biomarker for Gallbladder Carcinoma and Intrahepatic Cholangiocarcinoma.血清CYFRA 21-1在胆道癌中的作用:胆囊癌和肝内胆管癌的可靠生物标志物
Dig Dis Sci. 2015 May;60(5):1273-83. doi: 10.1007/s10620-014-3472-0. Epub 2014 Dec 9.
5
R0 but not R1/R2 resection is associated with better survival than palliative photodynamic therapy in biliary tract cancer.R0 切除术而非 R1/R2 切除术与胆道癌患者的生存改善相关,优于姑息性光动力疗法。
Liver Int. 2011 Jan;31(1):99-107. doi: 10.1111/j.1478-3231.2010.02345.x. Epub 2010 Sep 16.
6
Patterns of gene mutations in bile duct cancers: is it time to overcome the anatomical classification?胆管癌的基因突变模式:是否到了克服解剖分类的时候了?
HPB (Oxford). 2019 Dec;21(12):1648-1655. doi: 10.1016/j.hpb.2019.04.002. Epub 2019 May 20.
7
Long-Term Oncologic Outcomes Following Robotic Liver Resections for Primary Hepatobiliary Malignancies: A Multicenter Study.机器人肝切除术治疗原发性肝胆恶性肿瘤的长期肿瘤学结果:一项多中心研究。
Ann Surg Oncol. 2018 Sep;25(9):2652-2660. doi: 10.1245/s10434-018-6629-9. Epub 2018 Jul 9.
8
Time to Recurrence After Surgical Resection and Survival After Recurrence Among Patients with Perihilar and Distal Cholangiocarcinomas.肝门部和远端胆管癌患者手术切除后的复发时间和复发后的生存时间。
Ann Surg Oncol. 2020 Oct;27(11):4171-4180. doi: 10.1245/s10434-020-08534-2. Epub 2020 May 3.
9
Prognosis and prognostic factors in patients with advanced biliary tract cancer depending on its anatomical location.根据解剖位置分析晚期胆管癌患者的预后及预后因素
Scand J Gastroenterol. 2019 Jun;54(6):740-745. doi: 10.1080/00365521.2019.1619827. Epub 2019 May 28.
10
A single institution's experience with robotic resections of biliary tract cancers: an analysis of the short-term outcomes and long-term survival.单一机构开展机器人辅助胆管癌切除术的经验:短期结局与长期生存分析
J Gastrointest Surg. 2024 Sep;28(9):1498-1504. doi: 10.1016/j.gassur.2024.06.021. Epub 2024 Jun 26.

引用本文的文献

1
Blurring the Anatomical Lines in Extrahepatic Cholangiocarcinoma: An Integrated Clinic-Oncological and Exploratory Proteomic Comparison of Perihilar and Distal Tumors.肝外胆管癌中解剖学界限的模糊:肝门部和远端肿瘤的临床肿瘤学综合及探索性蛋白质组学比较
Ann Surg Oncol. 2025 Jul 16. doi: 10.1245/s10434-025-17811-x.
2
Preoperative factors predicting outcomes in patients with suspected perihilar cholangiocarcinoma referred for curative resection- a single-center 10-year experience.预测接受根治性切除术的疑似肝门部胆管癌患者预后的术前因素——单中心10年经验
Langenbecks Arch Surg. 2024 Dec 21;410(1):13. doi: 10.1007/s00423-024-03583-7.
3
Thioredoxin System Protein Expression in Carcinomas of the Pancreas, Distal Bile Duct, and Ampulla in the United Kingdom.
硫氧还蛋白系统蛋白在英国胰腺癌、远端胆管癌和壶腹癌中的表达
Diseases. 2024 Sep 24;12(10):227. doi: 10.3390/diseases12100227.
4
A Novel Approach to Quantify Heterogeneity of Intrahepatic Cholangiocarcinoma: The Hidden-Genome Classifier.一种量化肝内胆管癌异质性的新方法:隐藏基因组分类器。
Clin Cancer Res. 2024 Aug 15;30(16):3499-3511. doi: 10.1158/1078-0432.CCR-24-0657.
5
The road to tailored adjuvant chemotherapy for all four non-pancreatic periampullary cancers: An international multimethod cohort study.为所有四种非胰周壶腹周围癌制定个体化辅助化疗方案的道路:一项国际多方法队列研究。
Br J Cancer. 2024 Jul;131(1):117-125. doi: 10.1038/s41416-024-02692-w. Epub 2024 May 28.
6
Current progress in perioperative chemotherapy for biliary tract cancer.胆道癌围手术期化疗的当前进展
Ann Gastroenterol Surg. 2023 May 16;7(4):565-571. doi: 10.1002/ags3.12691. eCollection 2023 Jul.
7
Molecular profiling and treatment pattern differences between intrahepatic and extrahepatic cholangiocarcinoma.肝内型和肝外型胆管细胞癌的分子谱和治疗模式差异。
J Natl Cancer Inst. 2023 Jul 6;115(7):870-880. doi: 10.1093/jnci/djad046.
8
The new insight of treatment in Cholangiocarcinoma.胆管癌治疗的新见解。
J Cancer. 2022 Jan 1;13(2):450-464. doi: 10.7150/jca.68264. eCollection 2022.
9
Limited Impact of HER2 Expression on Survival Outcomes in Patients with Intrahepatic Cholangiocarcinoma After Surgical Resection.手术切除后,HER2 表达对肝内胆管癌患者生存结局的影响有限。
Oncologist. 2021 Oct;26(10):e1893-e1894. doi: 10.1002/onco.13884. Epub 2021 Jul 10.
10
High sensitivity of ROSE-supported ERCP-guided brushing for biliary strictures.ROSE支持的ERCP引导下胆管狭窄刷检的高敏感性
Endosc Int Open. 2021 Mar;9(3):E363-E370. doi: 10.1055/a-1322-2638. Epub 2021 Feb 19.